Researcher.Life Logo

FEBS Open Bio : Impact Factor & More

eISSN: 2211-5463pISSN: 2211-5463
JournalOpen Access

Key Metrics

CiteScore
3.9
Impact Factor
< 5
SJR
Q2Biochemistry, Genetics and Molecular Biology (all)
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on FEBS Open Bio

FEBS Open Bio Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Continuous publication
Article Processing ChargesUSD 1750
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorFederation of European Biochemical Societies
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in FEBS Open Bio ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in FEBS Open Bio

Acute caffeine treatment protects the developing retina from ischemia-induced cell death.
  • 13 May 2026
  • FEBS open bio
Emerging insights into CC and CXC chemokines and their receptors in Mycobacterium tuberculosis infection.
  • 12 May 2026
  • FEBS open bio
Directed evolution of enzymes at the crossroads of tradition and innovation.
  • 12 May 2026
  • FEBS open bio
The crystal structure of the Borrelia burgdorferi nicotinamidase BBE22 resolves a long-standing annotation error.
  • 11 May 2026
  • FEBS open bio
Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice.
  • 7 May 2026
  • FEBS open bio
UiO-66 metal-organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy.
  • 4 May 2026
  • FEBS open bio
Acute caffeine treatment protects the developing retina from ischemia-induced cell death.
  • 13 May 2026
  • FEBS open bio
Emerging insights into CC and CXC chemokines and their receptors in Mycobacterium tuberculosis infection.
  • 12 May 2026
  • FEBS open bio
Directed evolution of enzymes at the crossroads of tradition and innovation.
  • 12 May 2026
  • FEBS open bio
The crystal structure of the Borrelia burgdorferi nicotinamidase BBE22 resolves a long-standing annotation error.
  • 11 May 2026
  • FEBS open bio
Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice.
  • 7 May 2026
  • FEBS open bio
UiO-66 metal-organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy.
  • 4 May 2026
  • FEBS open bio

FAQs on FEBS Open Bio